{
    "2021-07-07": [
        [
            {
                "time": "2019-07-13",
                "original_text": "药明康德(02359)2019年限制性股票与股票期权激励计划首次授予股票期权于7月13日-8月12日限制行权",
                "features": {
                    "keywords": [
                        "药明康德",
                        "限制性股票",
                        "股票期权",
                        "激励计划"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "药监局新政重挫“伪创新” CXO、生物制药板块三日杀跌",
                "features": {
                    "keywords": [
                        "药监局",
                        "新政",
                        "伪创新",
                        "CXO",
                        "生物制药",
                        "杀跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-06",
                "original_text": "沪股通连续4日净卖出药明康德累计净卖出8.87亿元",
                "features": {
                    "keywords": [
                        "沪股通",
                        "净卖出",
                        "药明康德"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "2020年业绩快报显示，2020年全年净亏损4.07亿元，上年同期亏损1.57亿元。",
                "features": {
                    "keywords": [
                        "业绩快报",
                        "净亏损",
                        "2020年"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-01",
                "original_text": "医药：CDE临床研发指导原则驱动新药研发规范化发展",
                "features": {
                    "keywords": [
                        "CDE",
                        "临床研发",
                        "指导原则",
                        "新药研发"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-28",
                "original_text": "抗肿瘤药物遭遇政策黑天鹅 医药股地震上演“过山车”行情 自然灾害",
                "features": {
                    "keywords": [
                        "抗肿瘤药物",
                        "政策黑天鹅",
                        "医药股",
                        "过山车",
                        "自然灾害"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "药明康德：股价波动更多还是受市场情绪影响 | 公司问答",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股价波动",
                        "市场情绪"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "医药龙头全线反弹，迈瑞医疗、凯莱英涨近6%",
                "features": {
                    "keywords": [
                        "医药龙头",
                        "反弹",
                        "迈瑞医疗",
                        "凯莱英"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-05",
                "original_text": "CDE新政引发CRO公司暴跌？真实内因或许是...",
                "features": {
                    "keywords": [
                        "CDE",
                        "新政",
                        "CRO",
                        "暴跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}